Richard Perry

Summary

Publications

  1. doi request reprint Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder
    Richard Perry
    Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York 11201, USA
    Clin Ther 31:1374-404. 2009

Detail Information

Publications1

  1. doi request reprint Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder
    Richard Perry
    Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York 11201, USA
    Clin Ther 31:1374-404. 2009
    ..Desvenlafaxine is the third SNRI approved by the FDA for this indication...